# Precision Functional Brain Mapping in Psilocybin

> **NCT04501653** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 11 (actual)

## Conditions studied

- Psilocybin

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT04501653
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-03-19
- **Final completion:** 2023-03-19
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04501653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04501653, "Precision Functional Brain Mapping in Psilocybin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04501653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*